| Ident. | Authors (with country if any) | Title |
|---|
| 000199 |
P. N. Nelson [Australie] ; M. J. Webb [Australie] ; M. Banabas [Guinée] ; S. Nake [Guinée] ; I. Goodrick [Australie] ; J. Gordon [Australie] ; D. O'Grady [Australie] ; B. Dubos [France] | Methods to account for tree-scale variability in soil-and plant-related parameters in oil palm plantations |
| 000653 |
Luis Fayad [États-Unis] ; Fritz Offner [Belgique] ; Mitchell R. Smith [États-Unis] ; Gregor Verhoef [Belgique] ; Peter Johnson [Royaume-Uni] ; Jonathan L. Kaufman [États-Unis] ; Ama Rohatiner [Royaume-Uni] ; Anjali Advani [États-Unis] ; James Foran [États-Unis] ; Georg Hess [Allemagne] ; Bertrand Coiffier [France] ; Myron Czuczman [États-Unis] ; Eva Gine [Espagne] ; Simon Durrant [Australie] ; Michelle Kneissl [États-Unis] ; Kenneth T. Luu [États-Unis] ; Steven Y. Hua [États-Unis] ; Joseph Boni [États-Unis] ; Erik Vandendries [États-Unis] ; Nam H. Dang [États-Unis] | Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab |
| 000721 |
Vanessa Maroga Mboula [France] ; Valérie Hequet [France] ; Yves Andres [France] ; Luisa Maria Pastrana-Martinez [Portugal] ; José Miguel Dona-Rodriguez [Espagne] ; Adrián M. T. Silva [Portugal] ; Polycarpos Falaras [Grèce] | Photocatalytic degradation of endocrine disruptor compounds under simulated solar light |
| 000739 |
Madeleine Duvic [États-Unis] ; Reinhard Dummer [Suisse] ; Jürgen C. Becker [Autriche] ; Nicolas Poulalhon [France] ; Pablo Ortiz Romero [Espagne] ; Maria Grazia Bernengo [Italie] ; Celeste Lebbe [France] ; Chalid Assaf [Allemagne] ; Margaret Squier [États-Unis] ; Denise Williams [États-Unis] ; Miriam Marshood [États-Unis] ; FENG TAI [États-Unis] ; H. Miles Prince [Australie] | Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial |
| 000B53 |
C. Faivre [France] ; D. Barbolosi [France] ; E. Pasquier [Australie, France] ; N. Andre [France] | A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens |
| 000C12 |
Anne Casset [Autriche] ; Adriano Mari [Italie] ; Ashok Purohit [France] ; Yvonne Resch [Autriche] ; Margit Weghofer [Autriche] ; Rosetta Ferrara [Italie] ; Wayne R. Thomas [Australie] ; Claudia Alessandri [Italie] ; Kuan-Wei Chen [Autriche] ; Frederic De Blay [France] ; Rudolf Valenta [Autriche] ; Susanne Vrtala [Autriche] | Varying Allergen Composition and Content Affects the in vivo Allergenic Activity of Commercial Dermatophagoides pteronyssinus Extracts |
| 001068 |
Didier Lebrec [France] ; Jaime Bosch [Espagne] ; Rajiv Jalan [Royaume-Uni] ; Francis J. Dudley [Australie] ; Rada Jessic [Serbie] ; Richard Moreau [France] ; Juan Carlos Garcia-Pagan [Espagne] ; Rajeshwar P. Mookerjee [Royaume-Uni] ; Eleonora Chiossi [Suisse] ; Paul L. M. Van Giersbergen [Suisse] ; Andjela Kusic-Pajic [Suisse] ; Jasper Dingemanse [Suisse] | Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis |
| 001303 |
C. Twelves [Royaume-Uni] ; W. Scheithauer [Autriche] ; J. Mckendrick [Australie] ; J.-F. Seitz [France] ; G. Van Hazel [Australie] ; A. Wong [Canada] ; E. Diaz-Rubio [Espagne] ; F. Gilberg [Suisse] ; J. Cassidy [Royaume-Uni] | Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy |
| 001D33 |
Lionel Ho [Australie] ; Charlotte Grasset [France] ; Daniel Hoefel [Australie] ; Mike B. Dixon [Australie] ; Frederic D. L. Leusch [Australie] ; Gayle Newcombe [Australie] ; Christopher P. Saint [Australie] ; Justin D. Brookes [Australie] | Assessing granular media filtration for the removal of chemical contaminants from wastewater |
| 002012 |
Bernard Malavaud [France] ; Dimitri Pchejetski [France] ; Catherine Mazerolles [France] ; Geisilène Russano De Paiva [France] ; Cyril Calvet [France] ; Nicolas Doumerc [France] ; Stuart Pitson [Australie] ; Pascal Rischmann [France] ; Olivier Cuvillier [France] | Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens |
| 002109 |
Aaron Reynolds [Australie] ; Raphy Hanani [Australie] ; David Hibbs [Australie] ; Annelaure Damont [France] ; Eleonora Da Pozzo [Italie] ; Silvia Selleri [Italie] ; Frédéric Dolle [France] ; Claudia Martini [Italie] ; Michael Kassiou [Australie] | Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO) |
| 002192 |
Alexandre Ganachaud [France] ; Andrés Vega ; Martine Rodier ; Cécile Dupouy ; Christophe Maes ; Patrick Marchesiello ; Gerard Eldin [France] ; Ken Ridgway [Australie] ; Robert Le Borgne | Observed impact of upwelling events on water properties and biological activity off the southwest coast of New Caledonia |
| 002987 |
Benjamin Maneglier [France] ; Benoit Malleret [France, Singapour] ; Gilles J. Guillemin [Australie] ; Odile Spreux-Varoquaux [France] ; Philippe Devillier [France] ; Christine Rogez-Kreuz [France] ; Fabrice Porcheray [France] ; Patrice Therond [France] ; Dominique Dormont [France] ; Pascal Clayette [Australie] | Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages |
| 002D05 |
Duncan J. Campbell [Australie] ; Juerg Nussberger [Suisse] ; Michael Stowasser [Australie] ; A. H. Jan Danser [Pays-Bas] ; Alberto Morganti [Italie] ; Erik Frandsen [Danemark] ; Joël Menard [France] | Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement |
| 002D06 |
Alan E. Richardson [Australie] ; José-Miguel Barea [Espagne] ; Ann M. Mcneill [Australie] ; Claire Prigent-Combaret [France] | Acquisition of phosphorus and nitrogen in the rhizosphere and plant growth promotion by microorganisms |
| 002D99 |
Hai-Tao Zhao [Australie] ; Isabelle Hazemann [France] ; Andre Mitschler [France] ; Vincenzo Carbone [Australie] ; Andrzej Joachimiak [États-Unis] ; Steve Ginell [États-Unis] ; Alberto Podjamy [France] ; Ossama El-Kabbani [Australie] | Unusual Binding Mode of the 2S4R Stereoisomer of the Potent Aldose Reductase Cyclic Imide Inhibitor Fidarestat (2S4S) in the 15 K Crystal Structure of the Ternary Complex Refined at 0.78 Å Resolution : Implications for the Inhibition Mechanism |
| 002E87 |
Victoria Gomez-Roldan [France] ; Soraya Fermas [France] ; Philip B. Brewer [Australie] ; Virginie Puech-Pages [France] ; Elizabeth A. Dun [Australie] ; Jean-Paul Pillot [France] ; Fabien Letisse [France] ; Radoslava Matusova [Pays-Bas] ; Saida Danoun [France] ; Jean-Charles Portais [France] ; Harro Bouwmeester [Pays-Bas] ; Guillaume Becard [France] ; Christine A. Beveridge [Australie] ; Catherine Rameau [France] ; Soizic F. Rochange [France] | Strigolactone inhibition of shoot branching |
| 003291 |
Laurent Besret [France] ; Frédéric Dolle [France] ; Anne-Sophie Herard [France] ; Martine Guillermier [France] ; Stéphane Demphel [France] ; Francoise Hinnen [France] ; Christine Coulon [France] ; Michèle Ottaviani [France] ; Michel Bottlaender [France] ; Philippe Hantraye [France] ; Michael Kassiou [Australie] | Dopamine D1 Receptor Imaging in the Rodent and Primate Brain Using the Isoquinoline (+)-[11C]A-69024 and Positron Emission Tomography |
| 003405 |
K. A. Benhadji [France] ; M. Serova [France] ; A. Ghoul [France] ; E. Cvitkovic [France] ; C. Le Tourneau [France] ; S. M. Ogbourne [Australie] ; F. Lokiec [France] ; F. Calvo [France] ; P. Hammel [France] ; S. Faivre [France] ; E. Raymond [France] | Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells |
| 003424 |
Jérome Appenzeller [France] ; Ghezala Mihci [France] ; Marie-Thérèse Martin [France] ; Jean-Francois Gallard [France] ; Jean-Louis Menou ; Nicole Boury-Esnault [France] ; John Hooper [Australie] ; Sylvain Petek [France] ; Severine Chevalley [France] ; Alexis Valentin [France] ; Anne Zaparucha [France] ; Ali Al-Mourabit [France] ; Cécile Debitus [France] | Agelasines J, K, and L from the Solomon Islands Marine Sponge Agelas cf. mauritiana |
| 003489 |
B. Maneglier [France] ; O. Spreux-Varoquaux [France] ; G.-J. Guillemin [Australie] ; C. Rogez-Kreuz [France] ; D. Dormont [France] ; C. Advenier [France] ; P. Clayette [France] | Inhibition par la sérotonine de l'infection par VIH-1 des macrophages en culture primaire : rôle du sous-type 5-HT1A des récepteurs sérotoninergiques |
| 003616 |
Francoise Lohezic-Le Devehat [France] ; Sophie Tomasi [France] ; John A. Elix [Australie] ; Aurélie Bernard [France] ; Isabelle Rouaud [France] ; Philippe Uriac [France] ; Joel Boustie [France] | Stictic acid derivatives from the lichen usnea articulata and their antioxidant activities |
| 003719 |
Silvio Monfardini [Italie] ; M. S. Aapro [Suisse] ; J. M. Bennett [États-Unis] ; M. Mori [Japon] ; D. Regenstreif [États-Unis] ; M. Rodin [États-Unis] ; B. Stein [Australie] ; G. B. Zulian [Suisse] ; J. P. Droz [France] | Organization of the clinical activity of Geriatric Oncology : Report of a SIOG (International Society of Geriatric Oncology) task force |
| 003C44 |
Thaer Assaad [France] ; Sylvie Mavel [France] ; Stanley M. Parsons [États-Unis] ; Shane Kruse [États-Unis] ; Laurent Galineau [France] ; Hassan Allouchi [France] ; Michael Kassiou [Australie] ; Sylvie Chalon [France] ; Denis Guilloteau [France] ; Patrick Emond [France] | Synthesis and in vitro evaluation of N-substituted aza-trozamicol analogs as vesicular acetylcholine transporter ligands |
| 003D20 |
C. R. Chen [Australie] ; L. M. Condron [Nouvelle-Zélande] ; Z. H. Xu [Australie] ; M. R. Davis [Nouvelle-Zélande] ; R. R. Sherlock [Nouvelle-Zélande] | Root, rhizosphere and root-free respiration in soils under grassland and forest plants |
| 003D26 |
S. Zeuzem [Allemagne] ; A. Alberti [Italie] ; W. Rosenberg [Royaume-Uni] ; P. Marcellin [France] ; M. Diago [Espagne] ; F. Negro [Suisse] ; D. Prati [Italie] ; C. Puoti [Italie] ; S. K. Roberts [Australie] ; M. L. Shiffman [États-Unis] | Review article : management of patients with chronic hepatitis C virus infection and 'normal' alanine aminotransferase activity |
| 003F52 |
W. S. Guo [Australie] ; S. Vigneswaran [Australie] ; H. H. Ngo [Australie] ; T. B. Van Nguyen [Australie] ; R. Ben Aim [France] | Influence of bioreaction on a long-term operation of a submerged membrane adsorption hybrid system |
| 004149 |
Claudine Mazurier [France] | Composition, quality control, and labeling of plasma-derived products for the treatment of von willebrand disease |
| 004605 |
Tatiana Petrova [France] ; Holger Steuber [Allemagne] ; Isabelle Hazemann [France] ; Alexandra Cousido-Siah [France] ; Andre Mitschler [France] ; Roland Chung [Australie] ; Mitsuru Oka [Japon] ; Gerhard Klebe [Allemagne] ; Ossama El-Kabbani [Australie] ; Andrzej Joachimiak [États-Unis] ; Alberto Podjarny [France] | Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases : Structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex |
| 004D37 |
Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells |
| 004D88 |
Gaëlle Roger [France] ; Béatrice Lagnel [France] ; Laurent Besret [France] ; Yann Bramoulle [France] ; Christine Coulon [France] ; Michelle Ottaviani [France] ; Michael Kassiou [Australie] ; Michel Bottlaender [France] ; Heric Valette [France] ; Frédéric Dolle [France] | Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4-benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[11C]one, as a potent NR1A/2B subtype selective NMDA PET radiotracer |
| 004E68 |
Jean-Marie Boeynaems [Belgique] ; Francoise Wilkin [Belgique] ; Frédéric Marteau [Belgique] ; Xavier Duhant [Belgique] ; Pierre Savi [France] ; Nathalie Suarez Gonzalez [Belgique] ; Bernard Robaye [Belgique] ; Didier Communi [Belgique] | P2Y receptors: New subtypes, new functions |
| 004F25 |
G. Van Niel [France] ; J. Mallegol [France] ; C. Bevilacqua [France] ; C. Candalh [France] ; S. Brugiere [France] ; E. Tomaskovic-Crook [Australie] ; J. K. Heath [Australie] ; N. Cerf-Bensussan [France] ; M. Heyman [France] | Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice |
| 004F84 |
M. Ursula Norman [Australie] ; Shane B. Reeve [Australie] ; Vincent Dive [France] ; A. Ian Smith [Australie] ; Rebecca A. Lew [Australie] | Endopeptidases 3.4.24.15 and 24.16 in endothelial cells: potential role in vasoactive peptide metabolism : Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems |
| 005041 |
Philip J. Barter [Australie] ; H. Bryan Jr Brewer [États-Unis] ; M. John Chapman [France] ; Charles H. Hennekens [Norvège] ; Daniel J. Rader [États-Unis] ; Alan R. Tall [États-Unis] | Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis |
| 005155 |
Y. Soustre [France] ; B. Laurent [France] ; J. Schrezenmeira [Allemagne] ; M. Pleuffer [Allemagne] ; G. Miller [États-Unis] ; P. Parod [Australie] | Trans fatty acids |
| 005238 |
Charles R. Mcclain [États-Unis] ; James R. Christian [États-Unis] ; Sergio R. Signorini [États-Unis] ; Marlon R. Lewis [Canada] ; Ichio Asanuma [Japon] ; Daniela Turk [Canada] ; Cecile Dupouy-Douchement [France] | Satellite ocean-color observations of the tropical Pacific Ocean |
| 005359 |
A. R. Jones [Australie] ; C. Morin [France] ; W. Bone [Allemagne] ; T. G. Cooper [Allemagne] | Lack of antifertility properties of novel halogenated glycolytic inhibitors and the urinary excretion and metabolism of 1,6-dichloro-1,6-dideoxy-D-fructofuranose in the male rat |
| 005458 |
Meredith O'Keeffe [Australie, Allemagne, France] ; Hubertus Hochrein ; David Vremec ; Joanne Pooley ; Robert Evans ; Susan Woulfe ; Ken Shortman | Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice |
| 005501 |
Vincent Teste [France] ; Jean-Francois Briand [France] ; Brenton C. Nicholson [Australie] ; Simone Puiseux-Dao [France] | Comparison of changes in toxicity during growth of Anabaena circinalis (cyanobacteria) determined by mouse neuroblastoma bioassay and HPLC |
| 005552 |
Robert E. Widdop [Australie] ; Khalid Matrougui [France] ; Bernard I. Levy [France] ; Daniel Henrion [France] | AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade |
| 005596 |
| International Conference on Exogenous Factors Affecting Thrombosis and Haemostasis, Paris, July 12-13, 2001 |
| 005793 |
Chantal Etievant [France] ; Anna Kruczynski [France] ; Jean-Marc Barret [France] ; Alexandra S. Tait [Australie] ; Maria Kavallaris [Australie] ; Bridget T. Hill [France] | Markedly diminished drug resistance-inducing properties of vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro |
| 005831 |
David M. Livermore [Royaume-Uni] ; Michael W. Carter [Royaume-Uni] ; Simone Bagel [Allemagne] ; Bernd Wiedemann [Allemagne] ; Fernando Baquero ; Elena Loza [Espagne] ; Hubert P. Endtz [Pays-Bas] ; Nicole Van Den Braak [Pays-Bas] ; Clarence J. Fernandes [Australie] ; Lorna Fernandes [Australie] ; Niels Frimodt-Moller [Danemark] ; Laura S. Rasmussen [Danemark] ; Helen Giamarellou [Grèce] ; Evangelos Giamarellos-Bourboulis [Grèce] ; Vincent Jarlier [France] ; Jacqueline Nguyen [France] ; Carl-Erik Nord [Suède] ; Marc J. Struelens [Belgique] ; Caire Nonhoff [Belgique] ; John Turnidge [Australie] ; Jan Bell [Australie] ; Reinhard Zbinden [Suisse] ; Stefan Pfister ; Lori Mixson [États-Unis] ; Daniel L. Shungu [États-Unis] | In vitro activities of Ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia |
| 005901 |
Teresa Mancilla [Mexique] ; Lourdes Carrillo [Mexique] ; Luis S. Zamudio Rivera [Mexique] ; Carlos Camacho Camacho [Belgique] ; Dick De Vos [Pays-Bas] ; Robert Kiss [Belgique] ; Francis Darro [France] ; Bernard Mahieu [Belgique] ; Edward R. T. Tiekink [Australie] ; Hubert Rahier [Belgique] ; Marcel Gielen [Belgique] ; Martine Kemmer [Belgique] ; Monique Biesemans [Belgique] ; Rudolph Willem [Belgique] | Di-n-butyltin(iv) derivatives of bis(carboxymethyl)benzylamines : synthesis, NMR and X-ray structure characterization and in vitro antitumour properties |
| 005929 |
Dao-Yi Yu [États-Unis, Australie] ; Er-Ning Su [États-Unis] ; Stephen J. Cringle [États-Unis] ; Christian Schoch [Suisse] ; Christine P. Percicot [Suisse] ; George N. Lambrou [Suisse, France] | Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles |
| 005993 |
R. Rezaie [France] ; B. Joseph [France] ; J. B. Bremner [Australie] ; P. Delagrange [France] ; C. Kopp [France] ; R. Misslin [France] ; B. Pfeiffer [France] ; P. Renard [France] ; G. Guillaumet [France] | 5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors |
| 005A54 |
Jeannette N. Pham [Australie] ; Sydney M. Bell [Australie] ; Liliane Martin [France] ; Elisabeth Carniel [France] | The β-lactamases and β-lactam antibiotic susceptibility of Yersinia enterocolitica |
| 005A55 |
C. K. Rayner [Australie, France] ; Y.-C. Su ; S. M. Doran ; K. L. Jones ; C. H. Malbert ; M. Horowitz | The stimulation of antral motility by erythromycin is attenuated by hyperglycemia |
| 005D02 |
Jeffery L. Smith [Australie] ; Paul D. Roach [Australie] ; Leonie N. Wittenberg [Australie] ; Michel Riottot [France] ; S. Praga Pillay [Australie] ; Paul J. Nestel [Australie] ; Les K. Nathanson [Australie] | Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones |
| 005F12 |
W. R. Kem [États-Unis] ; M. W. Pennington [États-Unis] ; R. S. Norton [Australie] | Sea anemone toxins as templates for the design of immunosuppressant drugs |
| 006063 |
J. A. Upcroft [Australie] ; R. W. Campbell [Australie] ; K. Benakli [France] ; P. Upcroft [Australie] ; P. Vanelle [France] | Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. |
| 006096 |
G. A. Codd [Royaume-Uni] | Cyanobacterial toxins: their occurrence in aquatic environments and significance to health |
| 006407 |
J. Ong [Australie] ; D. I. B. Kerr [Australie] ; M. Ansar [France] ; C. Vaccher [France] ; P. Berthelot [France] | GABAB receptor antagonism by 7-MBFG, a benzo[b]furan analogue of baclofen, in central and peripheral tissues |
| 006438 |
J. Orgeas [Australie] ; C. Ballini [France] ; N. Poinsot-Balaguer [France] | Dynamics of holm oak (Quercus ilex L.) litter decomposition in isolated habitats, in grape-growing ecosystems |
| 006658 |
L. P. Rivory [Australie] ; M.-C. Haaz [France] ; P. Canal [France] ; F. Lokiec [France] ; J.-P. Armand [France] ; J. Robert [France] | Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials |
| 006665 |
P. Baille [France] ; R. Bruno [France] ; J. H. M. Schellens [Pays-Bas] ; L. K. Webster [Australie] ; M. Millward [Australie] ; J. Verweij [Pays-Bas] ; G. Montay [France] | Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance |
| 006742 |
N. J. Bodsworth [Australie, Royaume-Uni, Canada, Pays-Bas, France, Belgique, Nouvelle-Zélande, États-Unis] ; F. Boag ; D. Burdge ; M. Genereux ; J. C. C. Borleffs ; B. A. Evans ; J. Modai ; R. Colebunders ; M. Thomas ; D. Dehertogh ; L. Pacelli ; J. Thomis | Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults |
| 006815 |
J. Ong [Australie] ; D. I. B. Kerr [Australie] ; C. Vaccher [France] ; P. Berthelot [France] | Actions of thienyl analogs of baclofen at GABAB receptors in rat neocortical slices |
| 006935 |
L. P. Rivory [Australie, France] ; J.-F. Riou [États-Unis] ; M.-C. Haaz [France] ; S. Sable [États-Unis] ; M. Vuilhorgne [États-Unis] ; A. Commercon [États-Unis] ; S. M. Pond [Australie] ; J. Robert [France] | Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients |
| 006A89 |
P. J. Henry [Australie] ; R. G. Goldie | Endothelin-1, via activation of an ETB receptor, inhibits cholinergic nerve-mediated contractions in sheep trachea |
| 006A97 |
J. R. Redman [Australie] ; B. Guardiola-Lemaitre [France] ; M. Brown [Australie] ; P. Delagrange [France] ; S. M. Armstrong [Australie] | Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms |
| 006C18 |
C. J. Ormandy [Australie] ; C. S. L. Lee [Australie] ; P. A. Kelly [France] ; R. L. Sutherland [Australie] | Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells |
| 006D00 |
J. Sallis [Australie] ; J. Meehan ; H. Kamperman ; M. Anderson | Chemically modified phosphocitrate and entrapment in microparticles for sustained inhibition of biomineralization |
| 006D30 |
C. J. Ormandy [Australie] ; J. Graham [Australie] ; P. A. Kelly [France] ; C. L. Clarke [Australie] ; R. L. Sutherland [Australie] | The effect of progestins on prolactin receptor gene transcription in human breast cancer cells |
